Back
Instil Bio Vs. Zevra Therapeutics Industry Stock Comparison
Sell
16
TIL
Instil Bio
Last Price:
25.91
Seasonality Move:
-13.54%
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
9.63
Seasonality Move:
6.65%
Sell
16
Instil Bio (TIL)
is a Sell
Is Instil Bio a Buy, Sell or Hold?
- The current Instil Bio [TIL] share price is $26.15. The Score for TIL is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
- TIL is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $9.59. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TIL Stock Price Chart
What is Instil Bio's stock price today?
-
The Instil Bio share price today is $26.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TIL is experiencing buying pressure, which is a positive indicator for future bullish movement.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $9.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing buying pressure, which is a positive indicator for future bullish movement.
TIL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.33 | Sell |
Relative Strength Index (14 RSI): | 41.37 | Sell |
Chaikin Money Flow: | 48984 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.16 - 33.42) | Sell |
Bollinger Bands (100): | (9.06 - 47.08) | Sell |
ZVRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.29 | Buy |
Relative Strength Index (14 RSI): | 67.47 | Buy |
Chaikin Money Flow: | 525632 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.17 - 9.01) | Buy |
Bollinger Bands (100): | (6.44 - 8.48) | Buy |
TIL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 26.61 | Sell |
20-day SMA: | 29.12 | Sell |
50-day SMA: | 42.64 | Sell |
200-day SMA: | 19.61 | Buy |
8-day EMA: | 26.48 | Sell |
20-day EMA: | 29.47 | Sell |
50-day EMA: | 32.49 | Sell |
200-day EMA: | 24.01 | Buy |
ZVRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.94 | Buy |
20-day SMA: | 8.71 | Buy |
50-day SMA: | 8.19 | Buy |
200-day SMA: | 6.36 | Buy |
8-day EMA: | 9.03 | Buy |
20-day EMA: | 8.75 | Buy |
50-day EMA: | 8.23 | Buy |
200-day EMA: | 6.77 | Buy |
Instil Bio Earnings Growth & TIL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.13 per share, and a decrease next year of $3.32 per share.
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
Instil Bio Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Zevra Therapeutics Technical Analysis
Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |